Abstract |
Lymphatic filariasis is a major public health problem of tropical countries. Although its elimination is planned as global effort using mass drug administration in affected communities but its impact has been influenced by MDA coverage across countries. The drug coverage is affected by fever as side effect and its continuation for over 6 years which affect the population participation. Therefore alternative approaches are needed which can show impact faster than standard MDA. Present research using additional 12 days dose of DEC to mf carriers, show that if drug coverage could be regular, sustainable impact could be created in 4 years.
|
Authors | Anil Kumar, Pawan Sachan, Ashis Bajpei, Tejveer Singh |
Journal | The Journal of communicable diseases
(J Commun Dis)
2013 Mar-Jun
Vol. 45
Issue 1-2
Pg. 33-40
ISSN: 0019-5138 [Print] India |
PMID | 25141552
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Filaricides
- Diethylcarbamazine
|
Topics |
- Adolescent
- Child
- Child, Preschool
- Diethylcarbamazine
(administration & dosage, therapeutic use)
- Drug Administration Schedule
- Elephantiasis, Filarial
(drug therapy, prevention & control)
- Female
- Filaricides
(administration & dosage, therapeutic use)
- Humans
- India
(epidemiology)
- Male
- Preventive Health Services
(methods)
- Rural Health
- Rural Population
- Treatment Outcome
|